title: The concurrent use of N- and C-terminal antibodies anti-nucleophosmin 1 in immunofluorescence experiments allows for precise assessment of its subcellular localisation in acute myeloid leukaemia patients.
authors.forename: A M
authors.initials: AM
authors.lastname: Gruszka
authors.forename: C
authors.initials: C
authors.lastname: Martinelli
authors.forename: E
authors.initials: E
authors.lastname: Sparacio
authors.forename: P G
authors.initials: PG
authors.lastname: Pelicci
authors.forename: A
authors.initials: A
authors.lastname: de Marco
mesh_terms: D001323:Autoantibodies / Q000276:immunology*; D005455:Fluorescent Antibody Technique; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000378:metabolism* / Q000473:pathology; D009687:Nuclear Proteins / Q000276:immunology*; D000090243:Nucleophosmin; D013347:Subcellular Fractions / Q000276:immunology*
chemical_list: D001323:Autoantibodies; C000716967:NPM1 protein, human; D009687:Nuclear Proteins; D000090243:Nucleophosmin